P3 Health Partners Inc.·4/A

Jan 23, 6:13 PM ET

TOLAN MARY A 4/A

Research Summary

AI-generated summary

Updated

P3 Health Partners Director Mary Tolan Receives 2,000 RSUs

What Happened

  • Mary A. Tolan, a director of P3 Health Partners, was granted 2,000 restricted stock units (RSUs) on August 6, 2025. The grant was reported as an award (code A) at $0.00 per share (i.e., no cash paid).
  • Each RSU represents a right to receive one share of the company's Class A common stock. The RSUs vest upon the earlier of the company's 2026 annual stockholder meeting and the one‑year anniversary of the grant date.

Key Details

  • Transaction date: 2025-08-06; Grant type: RSUs (Code A); Amount: 2,000 RSUs; Reported price: $0.00.
  • Total cash paid: $0 (award/grant, not a purchase).
  • Footnote: The RSUs vest on the earlier of the 2026 annual meeting or one year after grant.
  • Amended filing: This Form 4 is an amendment to correct the number of securities beneficially owned after a 1-for-50 reverse stock split effective April 11, 2025. The amendment only corrects post‑split ownership reporting.
  • Shares owned after the transaction: not specified in the excerpt provided; the amended filing corrects the beneficial‑ownership column following the reverse split.

Context

  • This was an equity award, not a market purchase or sale; grants are common for directors and do not, by themselves, indicate buying or selling sentiment.
  • The RSUs convert to shares upon vesting (subject to the vesting schedule noted). No immediate exercise or sale was reported.